ADXN
Addex Therapeutics Ltd.Company with tickers: ADXN
CIK
1574232
CUSIP
00654J206
Shares Outstanding
1,265,844
13F Activity (30d)
2 filings
2 filers
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-18 | Teyssedou Lenaic Nathanael | PRINCIPAL ACCOUNTING OFFICER | Other | 0 |
| 2026-03-18 | Teyssedou Lenaic Nathanael | PRINCIPAL ACCOUNTING OFFICER | Other | 0 |
| 2026-03-18 | Teyssedou Lenaic Nathanael | PRINCIPAL ACCOUNTING OFFICER | Other | 0 |
| 2026-03-18 | Teyssedou Lenaic Nathanael | PRINCIPAL ACCOUNTING OFFICER | Other | 0 |
| 2026-03-18 | Teyssedou Lenaic Nathanael | PRINCIPAL ACCOUNTING OFFICER | Other | 0 |
| 2026-03-18 | Teyssedou Lenaic Nathanael | PRINCIPAL ACCOUNTING OFFICER | Other | 0 |
| 2026-03-18 | Lawton Vincent Michael | Director | Other | 2,507,987 |
| 2026-03-18 | Lawton Vincent Michael | Director | Other | 0 |
| 2026-03-18 | Kalinichev Mikhail | HEAD OF TRANSLATIONAL SCIENCE | Other | 0 |
| 2026-03-18 | Kalinichev Mikhail | HEAD OF TRANSLATIONAL SCIENCE | Other | 306,765 |
| 2026-03-18 | Mills Roger | Director, CHIEF MEDICAL OFFICER | Other | 785,976 |
| 2026-03-18 | Mills Roger | Director, CHIEF MEDICAL OFFICER | Other | 0 |
| 2026-03-18 | Dyer Timothy Mark | Director, Chief Executive Officer, 10% Owner | Other | 16,848,979 |
| 2026-03-18 | Dyer Timothy Mark | Director, Chief Executive Officer, 10% Owner | Other | 0 |
| 2026-03-18 | Nunn Jason Raleigh | Director | Other | 219,561 |
| 2026-03-18 | Nunn Jason Raleigh | Director | Other | 0 |
| 2026-03-18 | Manke Isaac | Director | Other | 0 |
| 2026-03-18 | Manke Isaac | Director | Other | 219,561 |
| 2026-03-18 | Teyssedou Lenaic Nathanael | PRINCIPAL ACCOUNTING OFFICER | Other | 0 |
| 2026-03-18 | Teyssedou Lenaic Nathanael | PRINCIPAL ACCOUNTING OFFICER | Other | 0 |
| 2026-03-18 | Hill Raymond George | Director | Other | 1,365,532 |
| 2026-03-18 | Hill Raymond George | Director | Other | 0 |